跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,111 条关于
“KP.3”
全部
36,111
临床试验
17,755
药物
4,740
机构
1,356
资讯
12,260
2个月前
Mirador Therapeutics Licenses KP-301, a Long-Acting Anti-C5a Antibody, Expanding into ANCA-Associated Vasculitis
2年前
FDA Updates Pemgarda EUA Due to Emerging SARS-CoV-2 Variants
2年前
Pfizer and BioNTech's Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive CHMP Opinion
去年
Invivyd's Pemivibart Shows Long-Term COVID-19 Protection in CANOPY Trial
2年前
Novavax COVID-19 Vaccine Targeting JN.1 Authorized for Emergency Use in the U.S.
去年
FDA Updates Pemgarda EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility Data
2年前
Updated COVID-19 Vaccines Targeting JN.1 and KP.2 Variants Show Promise
2个月前
Jasper Therapeutics Merges with Kira Pharmaceuticals, Secures $132 Million to Advance Complement and Immunology Pipeline
去年
EU Approves Novavax's Updated Nuvaxovid COVID-19 Vaccine Targeting JN.1 Variants
去年
FDA Lifts Clinical Hold on Novavax's Phase 3 COVID-19/Flu Vaccine Study
第 1 页,共 1226 页
上一页
下一页